← back to search

Catherine Regan

Pacific Biomarkers (United States) ·
Area of research
Epidemiology · Oncology
Research interest
Research interests include Cervical Cancer and HPV Research, Global Cancer Incidence and Screening, Head and Neck Cancer Studies, and Endometrial and Cervical Cancer Treatments.
h-index
17
citations
2,478
works
27
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

Human papillomavirus vaccination for adults aged 30 to 45 years in the United States: A cost-effectiveness analysis
PLoS Medicine 2021cited by 56position: middledoi
Impact of HPV vaccination and cervical screening on cervical cancer elimination: a comparative modelling analysis in 78 low-income and lower-middle-income countries
The Lancet 2020cited by 930position: middledoi
Mortality impact of achieving WHO cervical cancer elimination targets: a comparative modelling analysis in 78 low-income and lower-middle-income countries
The Lancet 2020cited by 648position: middledoi
Historical and projected hysterectomy rates in the USA: Implications for future observed cervical cancer rates and evaluating prevention interventions
Gynecologic Oncology 2020cited by 64position: middledoi
Estimating the Natural History of Cervical Carcinogenesis Using Simulation Models: A CISNET Comparative Analysis
JNCI Journal of the National Cancer Institute 2019cited by 85position: middledoi
Cost-Effectiveness of Cervical Cancer Screening in Women Living With HIV in South Africa: A Mathematical Modeling Study
JAIDS Journal of Acquired Immune Deficiency Syndromes 2018cited by 35position: middledoi
Health impact of delayed implementation of cervical cancer screening programs in India: A modeling analysis
International Journal of Cancer 2018cited by 18position: middledoi
The health and economic impact of scaling cervical cancer prevention in 50 low‐ and lower‐middle‐income countries
International Journal of Gynecology & Obstetrics 2017cited by 76position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jane J. Kim · Boston Medical Center7 papers (2018–2021)Stephen Sy · Harvard University6 papers (2018–2021)Karen Canfell · Sydney Local Health District5 papers (2019–2021)Emily A. Burger · OsloMet – Oslo Metropolitan University5 papers (2019–2021)Kate T. Simms · Cancer Council Australia5 papers (2019–2021)Nicole G. Campos · Harvard Global Health Institute3 papers (2017–2018)James Killen · The University of Sydney3 papers (2019–2021)Monisha Sharma · Seattle University2 papers (2017–2018)Diep Nguyen · The University of Sydney2 papers (2020–2020)Jean‐François Laprise · Centre hospitalier de l'Université Laval2 papers (2020–2020)Élodie Bénard · Université Laval2 papers (2020–2020)José Jerónimo · University of New Mexico2 papers (2018–2018)Marc Brisson · London Centre for Neglected Tropical Disease Research2 papers (2020–2020)Andrew Clark · Airbus (Italy)2 papers (2017–2018)Elena Fidarova · International Atomic Energy Agency2 papers (2020–2020)Mélanie Drolet · Centre hospitalier de l'Université Laval2 papers (2020–2020)Nathalie Broutet · World Health Organization - Pakistan2 papers (2020–2020)Adam Keane · Cancer Council NSW2 papers (2020–2020)Freddie Bray · Centre National de la Recherche Scientifique2 papers (2020–2020)Stephen Resch · Harvard University2 papers (2017–2018)